Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer study.
Azad NS, El-Khoueiry A, Yin J, Oberg AL, Flynn P, Adkins D, Sharma A, Weisenberger DJ, Brown T, Medvari P, Jones PA, Easwaran H, Kamel I, Bahary N, Kim G, Picus J, Pitot HC, Erlichman C, Donehower R, Shen H, Laird PW, Piekarz R, Baylin S, Ahuja N. Azad NS, et al. Among authors: erlichman c. Oncotarget. 2017 May 23;8(21):35326-35338. doi: 10.18632/oncotarget.15108. Oncotarget. 2017. PMID: 28186961 Free PMC article. Clinical Trial.
Optimum doses of irinotecan.
Erlichman C, Goldberg RM, Pitot HC, O'Connell MJ. Erlichman C, et al. Lancet. 1999 Apr 10;353(9160):1275-6. doi: 10.1016/s0140-6736(05)75197-7. Lancet. 1999. PMID: 10217115 No abstract available.
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy.
Pitot HC, Goldberg RM, Reid JM, Sloan JA, Skaff PA, Erlichman C, Rubin J, Burch PA, Adjei AA, Alberts SA, Schaaf LJ, Elfring G, Miller LL. Pitot HC, et al. Among authors: erlichman c. Clin Cancer Res. 2000 Jun;6(6):2236-44. Clin Cancer Res. 2000. PMID: 10873073 Clinical Trial.
Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.
Erlichman C, Adjei AA, Alberts SR, Sloan JA, Goldberg RM, Pitot HC, Rubin J, Atherton PJ, Klee GG, Humphrey R. Erlichman C, et al. Ann Oncol. 2001 Mar;12(3):389-95. doi: 10.1023/a:1011183905848. Ann Oncol. 2001. PMID: 11332153 Free article. Clinical Trial.
Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide.
Sloan JA, Atherton P, Reid J, Pitot HC, Erlichman C, Schaaf L. Sloan JA, et al. Among authors: erlichman c. Cancer Chemother Pharmacol. 2001 Sep;48(3):241-9. doi: 10.1007/s002800100296. Cancer Chemother Pharmacol. 2001. PMID: 11592347 Clinical Trial.
243 results